These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 21550133)

  • 1. Hereditary angioedema: diagnosis and management-a perspective for the dermatologist.
    Parish LC
    J Am Acad Dermatol; 2011 Oct; 65(4):843-850. PubMed ID: 21550133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary angioedema: a clinical review for the otolaryngologist.
    Anon JB
    Ear Nose Throat J; 2011 Jan; 90(1):32-9. PubMed ID: 21229509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
    Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the management of hereditary angioedema.
    Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
    J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
    Zeerleder S; Levi M
    Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
    Bork K
    Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Hereditary Angioedema.
    Caballero T
    J Investig Allergol Clin Immunol; 2021 Feb; 31(1):1-16. PubMed ID: 33602658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate.
    Tallroth GA
    Int Arch Allergy Immunol; 2011; 154(4):356-9. PubMed ID: 20975289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).
    Sabharwal G; Craig T
    Expert Rev Clin Immunol; 2015 Mar; 11(3):319-27. PubMed ID: 25669442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new?
    Zuraw BL
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S13-8. PubMed ID: 18220147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency.
    Frank MM; Zuraw B; Banerji A; Bernstein JA; Craig T; Busse P; Christiansen S; Davis-Lorton M; Li HH; Lumry WR; Riedl M;
    Pediatrics; 2016 Nov; 138(5):. PubMed ID: 27940765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for C1 esterase inhibitor deficiency in a Murine Model of Hereditary angioedema.
    Qiu T; Chiuchiolo MJ; Whaley AS; Russo AR; Sondhi D; Kaminsky SM; Crystal RG; Pagovich OE
    Allergy; 2019 Jun; 74(6):1081-1089. PubMed ID: 30059156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
    Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
    Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
    Wu MA; Zanichelli A; Mansi M; Cicardi M
    Expert Opin Pharmacother; 2016; 17(1):27-40. PubMed ID: 26512744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Pattern and Acute and Long-term Management of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency.
    Gómez-Traseira C; Pérez-Fernández E; López-Serrano MC; García-Ara MC; Pedrosa M; López-Trascasa M; Caballero T
    J Investig Allergol Clin Immunol; 2015; 25(5):358-64. PubMed ID: 26727765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
    Riedl M
    Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of long term treatments of type I hereditary angioedema in a Turkish family.
    Akoglu G; Kesim B; Yildiz G; Metin A
    An Bras Dermatol; 2017; 92(5):655-660. PubMed ID: 29166502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.
    Bork K
    Immunotherapy; 2014; 6(5):533-51. PubMed ID: 24635050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving patient outcomes in hereditary angioedema: reducing attack frequency using routine prevention with C1 inhibitor concentrate.
    Dominas N; Hoffmann TK; Bas M; Greve J
    BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24850548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.